PAPER
(E)-a-Bromoacrylates from Ando Phosphonates
2149
mol:mol:mol) as a colorless oil. The E:Z ratio of 38 prior to chroma-
IR (neat): 2985, 2940, 1715, 1645, 1615, 1435, 1370, 1310, 1275,
1220, 1165, 1040, 1025, 980, 825, 665 cm–1.
tography was 95:5 according to 1H NMR spectroscopy.
A specimen of pure (Z)-38 and a chlorine-free specimen of (E)-38
were prepared in analogy to the second procedure described for pre-
paring compound 36.
1H NMR (500.0 MHz, CDCl3): d = 1.27 (t, 3 H, J2¢,1¢ = 7.1 Hz, 2¢-
CH3), 1.46 and 1.48 [2 s, 3 H each, C(CH3)2], 1.93 (d, 3 H,
4J6-Me,7 = 1.2 Hz, 6-CH3), 3.75 (s, 3 H, OCH3), 4.18 (br d, 1 H,
J
5,4 = 8.2 Hz, 5-H), 4.19 (q, 2 H, J1¢,2¢ = 7.1 Hz, 1¢-CH2), 5.11 (dd, 1
(2E)-38
H, J4,5 = J4,3 = 8.4 Hz, 4-H), 5.90 (d, 1 H, 3J9,8 = 15.2 Hz, 9-H), 6.22
(dmc, 1 H, J7,8 = ca. 11.7 Hz, 7-H), 6.60 (d, 1 H, J3,4 = 8.5 Hz, 3-H),
7.56 (dd, 1 H, J8,9 = 15.2 Hz, J8,7 = 11.5 Hz, 8-H).
20
Rf = 0.31 (cyclohexane–EtOAc, 5:1); [a]D –30.6 (c = 0.75,
CHCl3).
13C NMR (125.7 MHz, CDCl3): d = 12.9 (6-CH3), 13.9 (C-2¢), 26.8
and 27.0 [C(CH3)2], 51.6 (OCH3), 62.7 (C-1¢), 76.5 (C-4), 84.9 (C-
5), 110.4 [C(CH3)2], 115.6 (C-2), 121.8 (C-9), 125.5 (C-7), 139.5
(C-8), 142.5 (C-6), 142.7 (C-3), 162.0 (C-1), 167.5 (9-C=O).
IR (neat): 2990, 2950, 1720, 1660, 1630, 1435, 1370, 1295, 1225,
1160, 1080, 1045, 895, 865, 830 cm–1.
1H NMR (500.0 MHz, CDCl3): d = 1.29 (t, 3 H, J2¢,1¢ = 7.1 Hz, 2¢-
CH3), 1.46 and 1.47 [2 s, 3 H each, C(CH3)2], 2.15 (d, 3 H,
4J6-Me,7 = 1.4 Hz, 6-CH3), 3.70 (s, 3 H, OCH3), 4.15 (hardly resolved
dd, 1 H, J5,4 = 8.2 Hz, 4J5,7 = 0.8 Hz, 5-H), 4.22 (q, 2 H, J1¢,2¢ = 7.1
Hz, 1¢-CH2), 5.08 (dd, 1 H, J4,5 = J4,3 = 8.5 Hz, 4-H), 5.96 (qd, 1 H,
4J7,6-Me = 4J7,5 = 1.3 Hz, 7-H), 6.61 (d, 1 H, J3,4 = 8.8 Hz, 3-H).
MS (EI, 70 eV): m/z (%) = 387 (10, [M – CH3]+), 192 (100).
Anal. Calcd for C17H23BrO6 (403.3): C, 50.63; H, 5.75. Found: C,
50.62; H, 5.81.
13C NMR (125.7 MHz, CDCl3): d = 13.9 (C-2¢), 14.5 (6-CH3), 26.7
and 27.0 [C(CH3)2], 51.1 (OCH3), 62.8 (C-1¢), 76.9 (C-4), 84.3 (C-
5), 110.7 [C(CH3)2], 116.3 (C-2), 117.1 (C-7), 142.1 (C-3), 153.0
(C-6), 162.0 (C-1), 166.5 (7-C=O).
Ethyl (2E,4S)-4-[(Benzyloxy)carbonylamino]-2-bromo-5-meth-
ylhex-2-enoate (42)
According to the general olefination procedure, a 64:36 mixture of
6b/7b [360.3 mg, containing 60 wt% 6b: 216.2 mg, 542.6 mmol,
0.83 equiv; 40 wt% 7b: 144.1 mg, 301.5 mmol, 0.46 equiv (total: 1.3
equiv); 2.3 mmol 6b/7b per g mixture], NaH (60% in mineral oil,
26.1 mg, 653 mmol, 1.0 equiv) and (S)-2-(benzyloxycarbonylami-
no)-3-methylbutanal28 (41; 153.1 mg, 653.3 mmol) were reacted for
3.5 h in THF (10 mL). Flash chromatography [∆ 2.5 cm, h 18 cm,
cyclohexane–EtOAc 5:1 (500 mL), 1–15 (20 mL), cyclohexane–
EtOAc 4:1 (500 mL), 16–40 (20 mL), (E)-42: 10–17, unreacted 6b/
7b: 18–21] provided the title compound (E)-42 (212.5 mg, 85%) as
a colorless oil. (Z)-42 was not detected; Rf = 0.65 (cyclohexane–
EtOAc 1:1); [a]D20 +18.6 (c = 0.81, CHCl3).
MS (CI, 40 eV): m/z (%) = 377 (28, [M + H]+), 318 (100).
Anal. Calcd for C15H21BrO6 (377.2): C, 47.76; H, 5.61. Found: C,
47.81; H, 5.76.
(2Z)-38
Rf = 0.25 (cyclohexane–EtOAc, 5:1).
IR (neat): 2980, 2925, 2855, 1730, 1715, 1650, 1560, 1535, 1495,
1455, 1370, 1260, 1220, 1160, 1080, 1045, 1035, 875, 820 cm–1.
1H NMR (500.0 MHz, CDCl3): d = 1.35 (t, 3 H, J2¢,1¢ = 7.2 Hz, 2-
CH3), 1.49 and 1.51 [2 s, 3 H each, C(CH3)2], 2.19 (d, 3 H,
4J6-Me,7 = 1.4 Hz, 6-CH3), 3.72 (s, 3 H, OCH3), 4.26 (dd, 1 H,
IR (neat): 3330, 2965, 2875, 1720, 1615, 1530, 1455, 1390, 1370,
1300, 1215, 1100, 1020, 905, 775, 740, 700 cm–1.
J
5,4 = 8.2 Hz, 4J5,7 = 0.8 Hz, 5-H), 4.31 (mc, 2 H, 1¢-CH2), 4.73 (dd,
1H NMR (499.9 MHz, 263 K, CDCl3, major:minor
rotamer = 80:20): major rotamer: d = 0.96 and 0.965 (2 d, 3 H each,
J5-Me,5/J6,5 = 6.8/6.9 Hz, 5-CH3, 6-CH3), 1.37 (t, 3 H, J2¢,1¢ = 7.1 Hz,
2¢-CH3), 1.90 (dqq, 1 H, J5,4 = J5,5-Me = J5,6 = 6.8 Hz, 5-H), 4.31 (q,
2 H, J1¢,2¢ = 7.1 Hz, 1¢-CH2), 4.86 (ddd, 1 H, J4,3 = J4,NH = 9.1 Hz,
1 H, J4,5 = J4,3 = 8.2 Hz, 4-H), 6.01 (qd, 1 H, 4J7,6-Me = 4J7,5 = 1.3 Hz,
7-H), 7.26 (d, 1 H, J3,4 = 8.8 Hz, 3-H).
13C NMR (125.7 MHz, CDCl3): d = 14.1 (C-2¢), 14.4 (6-CH3), 26.7
and 26.9 [C(CH3)2], 51.2 (OCH3), 63.0 (C-1¢), 78.9 (C-4), 84.0 (C-
5), 111.2 [C(CH3)2], 117.6 (C-7), 120.0 (C-2), 140.4 (C-3), 152.6
(C-6), 161.6 (C-1), 166.4 (7-C=O).
J
4,5 = 6.6 Hz, 4-H), 4.99 (d, 1 H, JNH,4 = 8.8 Hz, NH), 5.08 (s, 2 H,
benzyl-CH2), 6.48 (d, 1 H, J3,4 = 9.5 Hz, 3-H), 7.30–7.41 (m, 5 H,
Ar-H); minor rotamer: d = 0.94 and 0.972 (2 d, 3 H each, J5-Me,5
MS (CI, 40 eV): m/z (%) = 394 (100, [M + NH4]+), 377 (24, [M +
/
H]+).
J6,5 = ca. 7.0 Hz, 6-CH3, 5-CH3), 1.16 (t, 3 H, J2¢,1¢ = 7.1 Hz, 2¢-CH3),
1.76 (dqq, 1 H, J5,4 = J5,5-Me = J5,6 = 6.8 Hz, 5-H), 3.97–4.03 (m, 2
H, 1¢-H2), 4.79–4.84 (m, 1 H, 4-H), 4.94 (d, 1 H, JNH,4 = 8.8 Hz,
NH), 5.09 (s, 2 H, benzyl-CH2), 6.41 (d, 1 H, J3,4 = 9.7 Hz, 3-H),
7.30–7.41 (m, 5 H, Ar-H).
13C NMR (125.7 MHz, 263 K, CDCl3, major:minor
rotamer = 80:20): major rotamer: d = 14.0 (C-2¢), 18.1 and 19.0 (5-
CH3, C-6), 32.2 (C-5), 56.0 (C-4), 62.6 (C-1¢), 66.9 (benzyl-CH2),
113.3 (C-2), 128.3 (3 × CHarom), 128.5 (2 × CHarom), 135.9 (Cipso),
146.3 (C-3), 155.6 (carbamate-CO), 162.4 (C-1); minor rotamer:
d = 13.8 (C-2¢), 18.3 and 18.9 (5-CH3, 6-C), 32.1 (C-5), 56.6 (C-4),
62.4 (C-1¢), 67.1 (benzyl-CH2), 112.9 (C-2), 127.8 (2 × CHarom),
128.0 (Cpara), 128.4 (2 × CHarom), 135.8 (Cipso), 146.9 (C-3), 156.1
(carbamate-CO), 162.2 (C-1).
HRMS (EI): m/z calcd for C14H18BrO6 ([M – CH3]+): 361.0287;
found: 361.0288.
Ethyl (2E,4S,5S,6E,8E)-2-Bromo-4,5-dihydroxy-4,5-O,O-iso-
propylidene-9-(methoxycarbonyl)-6-methylnona-2,6,8-
trienoate (40)
According to the general olefination procedure, a 57:32:9:2 mixture
of 6b/7b/52/49 [1.057 g, containing 53.2 wt% 6b: 562.3 mg, 1.409
mmol, 0.71 equiv; 35.7 wt% 7b : 377.3 mg, 789.4 mmol, 0.40 equiv;
9.4 wt% 52: 99.4 mg, 221 mmol, 0.11 equiv; 1.7 wt% 49: 18.0 mg,
50.7 mmol, 0.025 equiv (total: 1.2 equiv); 2.2 mmol 6b/7b/52/49 per
g mixture], NaH (60% in mineral oil, 63.8 mg, 1.59 mmol, 0.80
equiv) and methyl (2E,4E,6S,7R)-6,7-dihydroxy-6,7-O,O-isopro-
pylidene-5-methyl-8-oxoocta-2,4-dienoate27 (39; 506.8 mg, 1.993
mmol) were reacted for 90 min in THF (25 mL). Flash chromatog-
raphy [∆ 5.5 cm, h 20 cm, cyclohexane–EtOAc, 10:1 (3300 mL),
1–26 (100 mL), 40 and 2-chloro-2-debromo-40: 11–22] provided
the title compound 40 and its chlorine analogue (651.1 mg, 81%,
40:2-chloro-2-debromo-40 = 93:7 mol:mol) as a colorless oil. The
E:Z ratio of 40 prior to chromatography was 98:2 according to 1H
MS (EI, 70 eV): m/z (%) = 383 (7, M+), 340 (16), 91 (100).
Anal. Calcd for C17H22BrNO4 (384.2): C, 53.14; H, 5.77; N, 3.65.
Found: C, 53.16; H, 5.77; N, 3.56.
Ethyl (2E,5S)-5-[(Benzyloxy)carbonylamino]-2-bromo-6-meth-
ylhept-2-enoate (44)
According to the general olefination procedure, a 64:36 mixture of
6b/7b [336.7 mg, containing 60 wt% 6b: 202.0 mg, 506.3 mmol,
0.83 equiv; 40 wt% 7b: 134.7 mg, 281.8 mmol, 0.46 equiv (total: 1.3
20
NMR spectroscopy; Rf = 0.65 (cyclohexane–EtOAc, 1:1); [a]D
–17.4 (c = 0.96, CHCl3).
Synthesis 2004, No. 13, 2135–2152 © Thieme Stuttgart · New York